Indivior Pharmaceuticals (INDV) EPS (Diluted) (2024 - 2026)
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) EPS (Diluted) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | -3.06 |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 7.27 |
| 10 | Indivior Pharmaceuticals | 4.04 Bn | 3.82 Bn | 294.00 Mn | 0.98 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.98 |
| Mar 31, 2026 | 0.69 |
| Dec 31, 2025 | 0.80 |
| Sep 30, 2025 | 0.33 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.38 |
| Dec 31, 2024 | 0.16 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | -0.73 |
| Mar 31, 2024 | 0.45 |